��ɫtv

News from ��ɫtv Langone Health

Second Patient To Receive A Genetically Modified Pig Kidney Has Died. (New York Times)

The (7/9) “A 54-year-old New Jersey woman who was the second person to receive a kidney transplanted from a genetically modified pig, and who lived with the organ for 47 days, died on Sunday, surgeons at ��ɫtv Langone Health announced on Tuesday.” Robert Montgomery, MD, PhD, the H. Leon Pachter, MD Professor of Surgery, chair, Department of Surgery, Transplant Institute said, “Lisa’s contributions to medicine, surgery and xenotransplantation cannot be overstated.”

(7/9) Dr. Montgomery added, “Lisa helped bring us closer to realizing a future where someone does not have to die for another person to live.”

Also reporting are Long Island, NY (7/9), the (7/9), (7/9), (7/9), (7/9), (7/9), (7/9), (7/9), the (7/9), and the (7/10).

What To Know About 6 Popular Home Tests For Allergies, Cancer And More. (Washington Post)

The (7/9) An article warning about drawbacks to at-home medical tests tells of a “95-year-old patient was sure she had colon cancer” after using an at-home colon cancer screening test, but her “physician, Mark B. Pochapin, MD, Sholtz-Leeds Professor of Medicine, Department of Medicine, Division of Gastroenterology and Hepatology, vice chair, Clinical Affairs Dept of Medicine, examined her, and found that she did not have cancer. Michael B. Natter, MD, clinical assistant professor, Department of Medicine, Holman Division of Endocrinology, Diabetes, and Metabolism, said, “A1C is a three-month average of blood sugar – and if someone is checking it, say every week or every month or every day and not realizing that those incremental changes are actually not something that you should be using to guide your management, it could be harmful or potentially fatal.”

Why Transgender Women Are At Higher Risk For HIV. (HealthyWomen)

(7/9) Although we often think about individual risk when we consider risk factors, Asa E. Radix, MD, PhD, clinical professor, Department of Medicine, Division of Infectious Diseases and Immunology, senior director of research and education at Callen-Lorde Community Health Center in New York City, clinical professor at ��ɫtv Langone Health, and a clinical ambassador for the CDC, said, “I think it’s really important to reframe that a little bit when we’re talking about HIV because this is often related to structural issues, not only individual-level issues.”

The Long View On The Long-Term Impact Of Breast Cancer Treatment. (MedPage Today)

(7/9) “‘Patient-related psychiatric and psychological risk predictors such as post-traumatic stress disorder, low mood, and anxiety commonly coexist and influence development of breast cancer-related pain,’ stated Lisa V. Doan, MD, associate professor, Department of Anesthesiology, Perioperative Care, and Pain Management in New York City, and colleagues in a recent review.”

Experts Discuss Breakthroughs In Large B-Cell Lymphoma At ASCO Annual Meeting. (MedPage Today)

(7/9) “MedPage Today brought together three expert leaders in the field for a roundtable discussion,” including Catherine S. Diefenbach, MD, associate professor, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center in New York City, about breakthroughs in treating lymphoma, where Dr. Diefenbach said, “So I think in all three of these diseases – large cell, follicular, and mantle cell – there’s going to be a real trade-off between risks and toxicities and durable benefits that is going to make the field really exciting over the next 5 to 10 years.”

Meta-Analysis Favors Complete Coronary Revascularization In A Single Go. (MedPage Today)

(7/9) “The latest evidence moves the needle closer in favor of one-go complete revascularization for people with acute myocardial infarction and multivessel coronary artery disease, according to an updated network meta-analysis” by Sripal Bangalore, MD, professor, Department of Medicine, the Leon H. Charney Division of Cardiology, and colleagues, who “found that single-setting complete revascularization ranked best for all outcomes, followed by staged complete revascularization, then culprit-only revascularization in third place.”

Does Frozen Cucumber Belong In Your Skincare Regimen? Here’s What Experts Say. (Health)

(7/9) Using something cold on the skin could cause the blood vessels to temporarily narrow, and “this blood vessel narrowing, or vasoconstriction effect, may make the skin look tighter, said Doris Day, MD, clinical associate professor, the Ronald O. Perelman Department of Dermatology.”

Special Episode: FDA Approves Donanemab For Early Symptomatic Alzheimer Disease. (Neurology Live)

(7/9) “This episode, ‘FDA Approves Donanemab for Early Symptomatic Alzheimer Disease,’ features an exclusive interview with Joel Salinas, MD, MBA, clinical assistant professor, Department of Neurology, the Pearl I. Barlow Center for Memory Evaluation and Treatment who “gave insight on the considerations and caution with prescribing donanemab, including the importance of identifying whether patients are a true candidate for treatment.”

Tips For Stopping Motion Sickness After It Starts – And How To Avoid It In The First Place. (Yahoo! News)

(7/10) The worst symptoms of motion sickness happen when the motion changes, according to Julia Adamian, MD, clinical associate professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation, who said, “For example, if you’re traveling by plane, it mostly happens during the ascent and descent because of the change of the pressure and those movements.”

Anthony Fauci’s Memoir Strikes A Crucial Blow Against The Disinformation Agents Who Imperil Our Health. (Los Angeles Times)

The (7/4) Fauci’s memoir is an “addition to the growing shelf of books by medical and scientific professionals fighting back against the tide of disinformation undermining public health in the US,” which includes “‘We Want Them Infected’ by neurologist Jonathan E. Howard, MD, associate professor, Departments of Neurology, and Pyschiatry, “which demolishes the claims of anti-vaccine ideologues such as Stanford’s Jay Bhattacharya.”